story of the week
Multiple Doses of Cagrilintide With Semaglutide 2.4 mg for Weight Management
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
Additional Info
Disclosure statements are available on the authors' profiles:
The Lancet
From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.
Safety, Tolerability, Pharmacokinetics, and Pharmacodynamics of Concomitant Administration of Multiple Doses of Cagrilintide With Semaglutide 2·4 mg for Weight Management: A Randomised, Controlled, Phase 1b Trial
Lancet 2021 Apr 22;[EPub Ahead of Print], LB Enebo, KK Berthelsen, M Kankam, MT Lund, DM Rubino, A Satylganova, DCW LauFrom MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.